Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Guillermo Torre Acquires 17,240 Shares

Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Guillermo Torre purchased 17,240 shares of the company’s stock in a transaction dated Thursday, December 26th. The stock was purchased at an average price of C$1.81 per share, with a total value of C$31,277.77.

Cardiol Therapeutics Price Performance

CRDL traded up C$0.01 on Thursday, reaching C$1.81. The stock had a trading volume of 10,756 shares, compared to its average volume of 134,137. The firm has a 50-day moving average of C$2.32 and a 200-day moving average of C$2.65. Cardiol Therapeutics Inc. has a fifty-two week low of C$1.09 and a fifty-two week high of C$4.26. The company has a market capitalization of C$126.48 million, a price-to-earnings ratio of -4.11 and a beta of 0.70. The company has a current ratio of 2.39, a quick ratio of 6.84 and a debt-to-equity ratio of 1.07.

About Cardiol Therapeutics

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.